期刊文献+

融合表达载体pET22b-SUMO-FGFR4的构建及其在大肠杆菌中表达条件的优化 被引量:5

Construction of fusion expression vector pET22b-SUMO-FGFR4 and optimization of expression conditions in E.coli
下载PDF
导出
摘要 目的:设计合成小泛素修饰物-成纤维细胞生长因子受体4(SUMO-FGFR4)基因,构建pET22bSUMO-FGFR4表达载体,并对其表达条件进行优化。方法:采用Overlap PCR方法制备SUMO-FGFR4融合基因,并连接到原核表达载体pET22b中,获得pET22b-SUMO-FGFR4重组表达载体。以乳糖为诱导剂,观察乳糖浓度、诱导时机、诱导温度、诱导时间和乳糖的添加方式等因素对SUMO-FGFR4蛋白表达量的影响,确定最佳诱导条件,并进行重组蛋白的可溶性分析。结果:pET22b-SUMO-FGFR4表达的融合蛋白在相对分子质量40 000处显示目标条带,并与FGFR4抗体特异性结合。融合蛋白在乳糖终浓度为1.0g·L-1、诱导时间为3h、诱导时机A(600)值为0.8、诱导温度为37℃时表达量最高,乳糖的添加方式对SUMO-FGFR4融合蛋白的表达量无明显影响。乳糖作为诱导剂比传统诱导剂IPTG诱导SUMO-FGFR4融合蛋白的表达量高7.5%,融合蛋白以包涵体形式为主。结论:以乳糖作为诱导剂,成功表达了SUMO-FGFR4融合蛋白,确定了融合蛋白的最佳表达条件。 Objective:To design the small ubiquitin modification-fibroblast growth factor receptor 4(SUMOFGFR4)fusion gene and construct the expression vector pET22b-SUMO-FGFR4,to optimize the expression conditions.Methods:The SUMO-FGFR4 fusion gene was obtained by Overlap PCR and was connected to pET22b;the recombinant expression vector pET22b-SUMO-FGFR4 was obtained.The influence of lactose concentration,induction time,induction temperature,induction point and adding mode of lactose in the expression levels was observed,and the best induction condition was determined;then the solubility of recombinant protein was analyzed.Results:The SUMO-FGFR4 fusion protein was highly expressed,the molecular weight of the fusion protein was about 40 000 and it could bind with FGFR4 specific antibody.When the lactose concentration was1.0g·L-1,the induction time was 3h,the induction temperature was 37℃,the value of A(600)was 0.8,the expression level was highest;but adding mode of lactose had no remarkable effect on the protein expression.The expression level of recombinant protein induced by lactose was higher than IPTG.SUMO-FGFR4 protein existed in a form of inclusion body.Conclusion:The SUMO-FGFR4 fusion protein is expressed successfully in this study while lactose is used as inducer and the best expression conditions are confirmed.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2016年第4期642-647,共6页 Journal of Jilin University:Medicine Edition
基金 国家自然科学基金资助课题(81273421) 吉林省卫计委青年项目资助课题(2015Q042) 吉林省吉林市科技局科技发展计划项目资助课题(20156427) 吉林省教育厅大学生创新创业训练项目资助课题(2015032)
关键词 小泛素相关修饰物 成纤维细胞生长因子受体4 重组融合蛋白类 small ubiquitin-like modifier fibroblast growth factor receptor 4 recombinant fusion proteins
  • 相关文献

参考文献17

  • 1杜彩萍,王梅,段富刚,侯筱宇.活化型及失活型SUMO1真核表达载体的构建及鉴定[J].生物技术,2014,24(5):12-16. 被引量:3
  • 2Ankara J,Sistonen L.SUMO:Getting iton[J].Biochemist Sock Trans,2007,35(6):1409-1413.
  • 3Li R,Wei J,Jiang C,et al.Act SUMO elation regulates cell proliferation and tumor genesis[J].Cancer Res,2013,73(18):5742-5753.
  • 4Wang W,Chen Y,Wang S,et al.PIASxαligase enhances SUMO1:Modification of PTEN protein as a SUMO E3ligase[J].J Boil Chem,2014,289(6):3217-3230.
  • 5Jouanneau J,Moens G,Thiery JP.The community effect in FGF-1mediated tumor progression of a rat bladder carcinoma does not involve a direct paracrine signaling[J].Oncogene,1999,18(2):327-333.
  • 6孔祥鑫,王会岩,李校堃.成纤维细胞生长因子受体4的研究[J].生命的化学,2010,30(5):717-722. 被引量:2
  • 7李祥,吕建新,彭颖,陈新文.脊椎动物成纤维细胞生长因子及其受体[J].解剖科学进展,2008,14(3):337-340. 被引量:3
  • 8Tanuma J,Izumo T,Hirano M,et al.FGFR4polymorphism,TP53 mutation,and their combinations are prognostic factors for oral squamous cell carcinoma[J].Oncol Rep,2010,23(3):739-744.
  • 9Fitzgerald LM,Karlis E,Karyadi DM,et al.Association of FGFR4genetic polymorphisms with prostate cancer risk and prognosis[J].Prostate Cancer Prostatic Dis,2009,12(2):192-197.
  • 10Murase H,Inokuchi M,Takagi Y,et al.Prognostic significance of the co-overexpression of fibroblast growth factor receptors 1,2and 4in gastric cancer[J].Mol Clin Oncol,2014,2(4):509-517.

二级参考文献109

共引文献8

同被引文献35

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部